Archives
The “o2h human health KI EIS fund” makes an investment into Neurocentrx 12 May, 2022
The “o2h human health SEIS fund” makes an investment into Neucruit 18 February, 2022
o2h Ventures makes a follow-on investment into Oxford Drug Design 18 February, 2022
o2h Ventures makes an investment into Xploro from “the o2h human health SEIS fund” 16 February, 2022
In4Derm raises £1.6m pre-Series A funding to support its growing pipeline of first-in-class anti-inflammatory and orphan disease therapeutics 3 November, 2021
o2h Ventures “Human Health SEIS Fund” Invests into Sanome… 7 October, 2021
o2h Ventures portfolio company Small Pharma Successfully Completes Phase I Clinical Trial of DMT-assisted therapy 22 September, 2021
o2h Ventures backed Arecor enters into an exclusive formulation collaboration with Intas Pharmaceuticals 8 September, 2021
o2h Ventures backed In4Derm enters into an exclusive license agreement with VYNE Therapeutics 13 August, 2021